Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 758656, 5 pages
http://dx.doi.org/10.1155/2010/758656
Review Article

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity

Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Michael White Diabetes Centre, 220-236 Analby Road, Hull Royal Infirmary, Hull HU3 2JZ, UK

Received 27 October 2009; Accepted 18 March 2010

Academic Editor: Giuseppe Matarese

Copyright © 2010 Thozhukat Sathyapalan and Stephen L. Atkin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Azziz, K. S. Woods, R. Reyna, T. J. Key, E. S. Knochenhauer, and B. O. Yildiz, “The prevalence and features of the polycystic ovary syndrome in an unselected population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2745–2749, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. Asuncion, R. M. Calvo, J. L. San Millan, J. Sancho, S. Avila, and H. F. Escobar-Morreale, “A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 7, pp. 2434–2438, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Ehrmann, “Polycystic ovary syndrome,” The New England Journal of Medicine, vol. 352, no. 12, pp. 1223–1236, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. J. C. Lo, S. L. Feigenbaum, J. Yang, A. R. Pressman, J. V. Selby, and A. S. Go, “Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1357–1363, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. Dahlgren, P. O. Janson, S. Johansson, L. Lapidus, and A. Oden, “Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women,” Acta Obstetricia et Gynecologica Scandinavica, vol. 71, no. 8, pp. 599–604, 1992. View at Google Scholar · View at Scopus
  6. E. Dahlgren, S. Johansson, G. Lindstedt et al., “Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones,” Fertility and Sterility, vol. 57, no. 3, pp. 505–513, 1992. View at Google Scholar · View at Scopus
  7. H.-Y. Son, A. Nishikawa, T. Ikeda, T. Imazawa, S. Kimura, and M. Hirose, “Lack of effect of soy isoflavone on thyroid hyperplasia in rats receiving an iodine-deficient diet,” Japanese Journal of Cancer Research, vol. 92, no. 2, pp. 103–108, 2001. View at Google Scholar · View at Scopus
  8. T. Pierpoint, P. M. McKeigue, A. J. Isaacs, S. H. Wild, and H. S. Jacobs, “Mortality of women with polycystic ovary syndrome at long-term follow-up,” Journal of Clinical Epidemiology, vol. 51, no. 7, pp. 581–586, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Wild, T. Pierpoint, H. Jacobs, and P. McKeigue, “Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study,” Human Fertility, vol. 3, no. 2, pp. 101–105, 2000. View at Google Scholar · View at Scopus
  10. E. O. Talbott, D. S. Guzick, K. Sutton-Tyrrell et al., “Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 11, pp. 2414–2421, 2000. View at Google Scholar · View at Scopus
  11. A. Vryonidou, A. Papatheodorou, A. Tavridou et al., “Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2740–2746, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. C. Christian, D. A. Dumesic, T. Behrenbeck, A. L. Oberg, P. F. Sheedy II, and L. A. Fitzpatrick, “Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2562–2568, 2003. View at Google Scholar · View at Scopus
  13. T. M. Barber, M. I. McCarthy, J. A. H. Wass, and S. Franks, “Obesity and polycystic ovary syndrome,” Clinical Endocrinology, vol. 65, no. 2, pp. 137–145, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J.-P. Bastard, C. Jardel, E. Bruckert et al., “Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3338–3342, 2000. View at Google Scholar · View at Scopus
  15. R. W. O'Rourke, T. Kay, E. A. Lyle et al., “Alterations in peripheral blood lymphocyte cytokine expression in obesity,” Clinical and Experimental Immunology, vol. 146, no. 1, pp. 39–46, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. A. Festa, R. D'Agostino Jr., K. Williams et al., “The relation of body fat mass and distribution to markers of chronic inflammation,” International Journal of Obesity, vol. 25, no. 10, pp. 1407–1415, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. Cancello, J. Tordjman, C. Poitou et al., “Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity,” Diabetes, vol. 55, no. 6, pp. 1554–1561, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. K. Clement, N. Viguerie, C. Poitou et al., “Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects,” FASEB Journal, vol. 18, no. 14, pp. 1657–1669, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. M. A. E. A. Diehl, “Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines,” American Journal of Physiology, vol. 282, no. 1, pp. G1–G5, 2002. View at Google Scholar · View at Scopus
  20. M. C. Arkan, A. L. Hevener, F. R. Greten et al., “IKK-β links inflammation to obesity-induced insulin resistance,” Nature Medicine, vol. 11, no. 2, pp. 191–198, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. U. Schonbeck, F. Mach, G. K. Sukhova et al., “CD40 ligation induces tissue factor expression in human vascular smooth muscle cells,” American Journal of Pathology, vol. 156, no. 1, pp. 7–14, 2000. View at Google Scholar · View at Scopus
  22. C. A. Reardon and G. S. Getz, “Mouse models of atherosclerosis,” Current Opinion in Lipidology, vol. 12, no. 2, pp. 167–173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Michelsen, M. H. Wong, P. K. Shah et al., “Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10679–10684, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. H. Wu, S. Ghosh, X. D. Perrard et al., “T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity,” Circulation, vol. 115, no. 8, pp. 1029–1038, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. U. Kintscher, M. Hartge, K. Hess et al., “T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, pp. 1304–1310, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. F. Licastro, G. Candore, D. Lio et al., “Innate immunity and inflammation in ageing: a key for understanding age-related diseases,” Immunity and Ageing, vol. 2, article 8, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. J. E. Davis, N. K. Gabler, J. Walker-Daniels, and M. E. Spurlock, “Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat,” Obesity, vol. 16, no. 6, pp. 1248–1255, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Schaeffler, P. Gross, R. Buettner et al., “Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-κB pathway in adipocytes links nutritional signalling with innate immunity,” Immunology, vol. 126, no. 2, pp. 233–245, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. G. Charriere, B. Cousin, E. Arnaud et al., “Preadipocyte conversion to macrophage: evidence of plasticity,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9850–9855, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. D. A. Ehrmann, R. B. Barnes, R. L. Rosenfield, M. K. Cavaghan, and J. Imperial, “Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome,” Diabetes Care, vol. 22, no. 1, pp. 141–146, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Dunaif, K. R. Segal, W. Futterweit, and A. Dobrjansky, “Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome,” Diabetes, vol. 38, no. 9, pp. 1165–1174, 1989. View at Google Scholar · View at Scopus
  32. R. J. Chang, R. M. Nakamura, H. L. Judd, and S. A. Kaplan, “Insulin resistance in nonobese patients with polycystic ovarian disease,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 2, pp. 356–359, 1983. View at Google Scholar · View at Scopus
  33. T. P. Ciaraldi, A. El-Roeiy, Z. Madar, D. Reichart, J. M. Olefsky, and S. S. C. Yen, “Cellular mechanisms of insulin resistance in polycystic ovarian syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 2, pp. 577–583, 1992. View at Publisher · View at Google Scholar · View at Scopus
  34. J. B. O'Driscoll, H. Mamtora, J. Higginson, A. Pollock, J. Kane, and D. C. Anderson, “A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia,” Clinical Endocrinology, vol. 41, no. 2, pp. 231–236, 1994. View at Google Scholar · View at Scopus
  35. R. S. Legro, V. D. Castracane, and R. P. Kauffman, “Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls,” Obstetrical and Gynecological Survey, vol. 59, no. 2, pp. 141–154, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. Z. T. Bloomgarden, “Inflammation and insulin resistance,” Diabetes Care, vol. 26, no. 6, pp. 1922–1926, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. W. H. Frishman, “Biologic markers as predictors of cardiovascular disease,” American Journal of Medicine, vol. 104, no. 6, pp. 18S–27S, 1998. View at Google Scholar · View at Scopus
  38. F. Orio Jr., S. Palomba, T. Cascella et al., “The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 2–5, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Human Reproduction, vol. 19, no. 1, pp. 41–47, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. C. C. J. Kelly, H. Lyall, J. R. Petrie, G. W. Gould, J. M. C. Connell, and N. Sattar, “Low grade chronic inflammation in women with polycystic ovarian syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 6, pp. 2453–2455, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Gonzalez, K. Thusu, E. Abdel-Rahman, A. Prabhala, M. Tomani, and P. Dandona, “Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome,” Metabolism, vol. 48, no. 4, pp. 437–441, 1999. View at Google Scholar · View at Scopus
  42. R. W. Alexander, “Inflammation and coronary artery disease,” The New England Journal of Medicine, vol. 331, no. 7, pp. 468–469, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Amato, M. Conte, G. Mazziotti et al., “Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles,” Obstetrics and Gynecology, vol. 101, no. 6, pp. 1177–1182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. H. F. Escobar-Morreale, G. Villuendas, J. I. Botella-Carretero, J. Sancho, and J. L. San Millan, “Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women,” Diabetologia, vol. 46, no. 5, pp. 625–633, 2003. View at Google Scholar · View at Scopus
  45. M. Mohlig, J. Spranger, M. Osterhoff et al., “The polycystic ovary syndrome per se is not associated with increased chronic inflammation,” European Journal of Endocrinology, vol. 150, no. 4, pp. 525–532, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. J. Puder, S. Varga, M. Kraenzlin, C. De Geyter, U. Keller, and B. Muller, “Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6014–6021, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, “Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance,” Science, vol. 259, no. 5091, pp. 87–91, 1993. View at Google Scholar · View at Scopus
  48. J. M. Stephens, M. D. Butts, and P. H. Pekala, “Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-α,” Journal of Molecular Endocrinology, vol. 9, no. 1, pp. 61–72, 1992. View at Google Scholar · View at Scopus
  49. S. Blankenberg, L. Tiret, C. Bickel et al., “Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina,” Circulation, vol. 106, no. 1, pp. 24–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Bringer, P. Lefebvre, F. Boulet et al., “Body composition and regional fat distribution in polycystic ovarian syndrome: relationship to hormonal and metabolic profiles,” Annals of the New York Academy of Sciences, vol. 687, pp. 115–123, 1993. View at Google Scholar · View at Scopus
  51. D. Panidis, A. Kourtis, D. Farmakiotis, T. Mouselech, D. Rousso, and G. Koliakos, “Serum adiponectin levels in women with polycystic ovary syndrome,” Human Reproduction, vol. 18, no. 9, pp. 1790–1796, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. C. J. G. Kelly, H. Lyall, J. R. Petrie et al., “A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 7, pp. 3287–3290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. T.-A. Jaatinen, I. Matinlauri, L. Anttila, P. Koskinen, R. Erkkola, and K. Irjala, “Serum total renin is elevated in women with polycystic ovarian syndrome,” Fertility and Sterility, vol. 63, no. 5, pp. 1000–1004, 1995. View at Google Scholar · View at Scopus
  54. R. S. Morris, I. L. Wong, I. E. Hatch, E. Gentschein, R. J. Paulson, and R. A. Lobo, “Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism,” Fertility and Sterility, vol. 64, no. 6, pp. 1099–1103, 1995. View at Google Scholar · View at Scopus
  55. E. Carmina, F. Orio, S. Palomba et al., “Evidence for altered adipocyte function in polycystic ovary syndrome,” European Journal of Endocrinology, vol. 152, no. 3, pp. 389–394, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. F. Orio Jr., S. Palomba, T. Cascella et al., “Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?” Reproductive BioMedicine Online, vol. 9, no. 5, pp. 505–510, 2004. View at Google Scholar · View at Scopus
  57. A. Dunaif, “Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis,” Endocrine Reviews, vol. 18, no. 6, pp. 774–800, 1997. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Sampson, C. Kong, A. Patel, R. Unwin, and H. S. Jacobs, “Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome,” Clinical Endocrinology, vol. 45, no. 5, pp. 623–629, 1996. View at Google Scholar · View at Scopus
  59. E. S. Sills, C. D. Drews, M. Perloe, M. J. Tucker, C. R. Kaplan, and G. D. Palermo, “Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system,” Gynecological Endocrinology, vol. 17, no. 3, pp. 231–237, 2003. View at Google Scholar · View at Scopus
  60. C. Karlsson, K. Lindell, E. Svensson et al., “Expression of functional leptin receptors in the human ovary,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 12, pp. 4144–4148, 1997. View at Google Scholar · View at Scopus
  61. L. J. Spicer and C. C. Francisco, “The adipose obese gene product, leptin: evidence of a direct inhibitory role in ovarian function,” Endocrinology, vol. 138, no. 8, pp. 3374–3379, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Caprio, E. Fabbrini, A. M. Isidori, A. Aversa, and A. Fabbri, “Leptin in reproduction,” Trends in Endocrinology and Metabolism, vol. 12, no. 2, pp. 65–72, 2001. View at Google Scholar · View at Scopus
  63. P. R. Brzechffa, A. J. Jakimiuk, S. K. Agarwal, S. R. Weitsman, R. P. Buyalos, and D. A. Magoffin, “Serum immunoreactive leptin concentrations in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 11, pp. 4166–4169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. I. M. Chapman, G. A. Wittert, and R. J. Norman, “Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters,” Clinical Endocrinology, vol. 46, no. 2, pp. 175–181, 1997. View at Google Scholar · View at Scopus
  65. J. Rouru, L. Anttila, P. Koskinen et al., “Serum leptin concentrations in women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, pp. 1697–1700, 1997. View at Google Scholar · View at Scopus
  66. C. S. Mantzoros, S. Moschos, I. Avramopoulos et al., “Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 10, pp. 3408–3413, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. M. H. Telli, M. Yildirim, and V. Noyan, “Serum leptin levels in patients with polycystic ovary syndrome,” Fertility and Sterility, vol. 77, no. 5, pp. 932–935, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. G. S. Conway and H. S. Jacobs, “Leptin: a hormone of reproduction,” Human Reproduction, vol. 12, no. 4, pp. 633–635, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Kirchengast and J. Huber, “Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome,” Human Reproduction, vol. 16, no. 6, pp. 1255–1260, 2001. View at Google Scholar · View at Scopus
  70. R. Horejsi, R. Moller, S. Rackl et al., “Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women,” American Journal of Physical Anthropology, vol. 124, no. 3, pp. 275–281, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus